T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity

por Lee, Sang-Eun, Shin, A-Ri, Sohn, Hyun-Jung, Cho, Hyun-Il, Kim, Tai-Gyu
Publicado en Cancer Res Treat (2020)

An effective peptide vaccine strategy circumventing clonal MHC heterogeneity of murine myeloid leukaemia

por Shin, A-Ri, Lee, Sang-Eun, Choi, Haeyoun, Sohn, Hyun-Jung, Cho, Hyun-Il, Kim, Tai-Gyu
Publicado en Br J Cancer (2020)

Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy

por Shin, Chang-Ae, Cho, Hyun-Woo, Shin, A-Ri, Sohn, Hyun-Jung, Cho, Hyun-Il, Kim, Tai-Gyu
Publicado en Oncotarget (2016)

Recent trends in hepatitis B virus infection in the general Korean population

por Kim, Hyuck, Shin, A Ri, Chung, Hoe Hoon, Kim, Min Kyoung, Lee, Ji Sung, Shim, Jae-Jun, Kim, Byung-Ho
Publicado 2013

A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy

por Cho, Hyun-Il, Kim, Un-Hee, Shin, A-Ri, Won, Ji-Na, Lee, Hyun-Joo, Sohn, Hyun-Jung, Kim, Tai-Gyu
Publicado en Br J Cancer (2018)

The miR-24-3p/p130Cas: a novel axis regulating the migration and invasion of cancer cells

por Kang, Hoin, Rho, Jun Gi, Kim, Chongtae, Tak, Hyosun, Lee, Heejin, Ji, Eunbyul, Ahn, Sojin, Shin, A-Ri, Cho, Hyun-Il, Huh, Yun Hyun, Song, Woo Keun, Kim, Wook, Lee, Eun Kyung
Publicado en Sci Rep (2017)